Expertise in
4
conditions

Dr. Saira Z. Sheikh

Rheumatology
University Of North Carolina Hospitals
101 Manning Dr, 
Chapel Hill,, NC 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
4
conditions
University Of North Carolina Hospitals
101 Manning Dr, 
Chapel Hill,, NC 

Overview

Saira Sheikh is a Rheumatologist practicing medicine in Chapel Hill,, North Carolina.

Dr. Sheikh is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Cutaneous Lupus Erythematosus (CLE), and Arthritis.

She is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 8 clinical trials. Dr. Sheikh is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in AZ

Hospital Affiliations

Unc Hospitals

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

University of North Carolina Hospitals
101 Manning Dr, Chapel Hill,, NC 27514

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
Enrollment Status: Completed
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drugs: Low Dose Mesenchymal Stem Cells, High Dose Mesenchymal Stem Cells
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: LY3361237
Study Phase: Phase 2
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Enrollment Status: Terminated
Publish Date: December 13, 2024
Intervention Type: Drug
Study Phase: Phase 3
LUPUS Brain: Transcranial Alternating Current Stimulation (tACS) to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With Systemic Lupus Erythematosus (SLE)
LUPUS Brain: Transcranial Alternating Current Stimulation (tACS) to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: June 27, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Drug: TAK-079
Study Phase: Phase 1
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
Internet-Based Pain Coping Skills Training (PainCOACH) for Patients With Lupus
Internet-Based Pain Coping Skills Training (PainCOACH) for Patients With Lupus
Enrollment Status: Completed
Publish Date: May 20, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
View 6 Less Clinical Trials

33 Total Publications

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.
"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 08, 2026
Similar Doctors
Expertise in
4
conditions
Dr. Ann M. Reed
Rheumatology | General Practice
Expertise in
4
conditions
Dr. Ann M. Reed
Rheumatology | General Practice
Referral may be required
Before you request

Duke University School Of Medicine

2301 Erwin Rd, Box 3352, 
Durham, NC 
 (9.6 miles away)
919-681-4080
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I have spent my career caring for children with autoimmune disorders and immune dysfunction. I have focused my work caring for children with juvenile dermatomyositis and auto inflammatory disorders. I have overseen a research program for 24 years studying the genetics and cause of human autoimmune disease, focused on dermatomyositis in children and adults. The long-term goal of my research team is to develop new biomarkers of diseases to identify those predisposed to develop disease, as well as monitor disease activity and response to treatment. Dr. Reed is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Juvenile Dermatomyositis, Dermatomyositis, Myositis, and Polymyositis. Dr. Reed is board certified in American Board Of Pediatrics, Pediatric Rheumatology. Dr. Reed is currently accepting new patients.

Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required
Before you request

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
 (19.7 miles away)
713-792-6161
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Maria Suarez-Almazor is a Rheumatologist practicing medicine in Cary, North Carolina. Dr. Suarez-Almazor is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Osteoporosis, and Knee Replacement. Dr. Suarez-Almazor is currently accepting new patients.

Expertise in
6
conditions
Dr. Beth L. Jonas
Rheumatology
Expertise in
6
conditions
Dr. Beth L. Jonas
Rheumatology
Referral may be required
Before you request

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (0.1 miles away)
919-966-4131
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Beth Jonas is a Rheumatologist practicing medicine in Chapel Hill, North Carolina. Dr. Jonas is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Dermatomyositis. Dr. Jonas is currently accepting new patients.

Frequently Asked Questions about Dr. Saira Z. Sheikh

How do I make an appointment with Dr. Saira Z. Sheikh?

You can book an appointment with Dr. Saira Z. Sheikh by calling their office at 984-974-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Saira Z. Sheikh a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Saira Z. Sheikh is classified as an Distinguished expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Saira Z. Sheikh specialize in?

While Dr. Saira Z. Sheikh is a Rheumatology, they have specific expertise in Systemic Lupus Erythematosus (SLE), Lupus Nephritis, and Cutaneous Lupus Erythematosus (CLE). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Saira Z. Sheikh participate in research or clinical trials?

Yes. Dr. Saira Z. Sheikh has published 33 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Dr. Saira Z. Sheikh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Saira Z. Sheikh accept my insurance?

Dr. Saira Z. Sheikh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 984-974-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sheikh's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile